Status:
COMPLETED
Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH
Lead Sponsor:
Samsung Medical Center
Conditions:
Lower Urinary Tract Symptoms
Benign Prostatic Hyperplasia
Eligibility:
MALE
50-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare of Efficacy and Safety Between Holmium Laser Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the Lower Urinary Tract S...
Eligibility Criteria
Inclusion
- 50 yrs or greater
- International prostatic symptom score \>= 12
- Bladder outlet obstruction confirmed by pressure-flow study (BOOI \> 20)
- Able to give fully informed consent
Exclusion
- Patients with urologic malignancies such as prostate cancer and bladder cancer
- Patients underwent urethral, prostate surgery
- Patients with urethral stricture or bladder diverticulum or bladder neck contracture
- Patients with histories of bacterial prostatitis within 1 year
- seems not to be appropriate to this study by the decision of investigators because of any other reasons
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
313 Patients enrolled
Trial Details
Trial ID
NCT00877669
Start Date
October 1 2008
End Date
December 1 2016
Last Update
December 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea